Tryp Therapeutics Announces Private Placement of Unsecured Convertible Debentures for Gross Proceeds of up to AUD$175,000

KELOWNA, BC / ACCESSWIRE / October 4, 2023 / Tryp Therapeutics Inc. (“Tryp”…

PharmAla Biotech announces Non-Brokered Private Placement Offering of up to an Aggregate of $5,000,000

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 12, 2023 (GLOBE NEWSWIRE) —…

Clearmind Medicine Announces IRB Approval to Conduct Clinical Trial on Alcohol Use Disorder

News provided by Clearmind Medicine, May 12, 2023 IMCA medical center’s ethics…

MindBio Therapeutics Corp (CSE: MBIO) Reveals Scientific Paper in World-First Take-Home, LSD-Microdosing Clinical Trial in 80 Healthy Participants

VANCOUVER, BC / ACCESSWIRE / May 9, 2023 / MindBio Therapeutics Corp. (CSE:MBIO); (the…

Enveric Biosciences Names Lynn Gallant Vice President, Clinical Operations, and Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Accomplished pharmaceutical industry leader brings to Enveric extensive experience in clinical operations,…

Silo Pharma Announces Expansion of Intellectual Property Portfolio

Silo Receives Issuance of U.S. Patent Covering SPC-15 Method for Treatment and…

FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John McGraw to Advisory Board

Mr. Allan, the 2017 winner of the prestigious Julia Levy Award, to…

FSD Pharma’s Team Advancing a New Approach to Multiple Sclerosis

Multiple sclerosis, or MS, is a degenerative neurological disorder that makes life…